Edition:
United Kingdom

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

3.89USD
22 Jun 2018
Change (% chg)

$0.64 (+19.69%)
Prev Close
$3.25
Open
$3.30
Day's High
$3.90
Day's Low
$3.11
Volume
454,305
Avg. Vol
38,845
52-wk High
$4.67
52-wk Low
$3.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.15 -0.047
FY 2017 Dec '17 0.11 -0.060
Sep '17 0.03 -0.086
Jun '17 0.01 -0.052
Mar '17 0.08 -0.057
FY 2016 Dec '16 0.04 -0.059
Sep '16 0.05 -0.067
Jun '16 0.15 -0.084
Mar '16 0.04 -0.076
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 82.81 32.74
P/E High - Last 5 Yrs. -- 289.15 45.73
P/E Low - Last 5 Yrs. -- 90.24 24.23
Beta 0.85 0.91 0.88
Price to Sales (TTM) 1,110.25 109.18 5.71
Price to Book (MRQ) -- 13.44 5.37
Price to Tangible Book (MRQ) -- 13.96 6.94
Price to Cash Flow (TTM) -- 70.39 23.32
% Owned Institutions 5.90 13.84 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.50
Dividend Yield - 5 Year Avg -- 0.25 1.51
Dividend 5 Year Growth Rate -- 1.64 5.32
Payout Ratio(TTM) -- 15.83 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -93.70 392.54 7.89
Sales (TTM) vs TTM 1 Yr. Ago -42.39 77.35 5.68
Sales - 5 Yr. Growth Rate -38.07 32.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 37.65 24.53 19.38
EPS (TTM) vs TTM 1 Yr. Ago 55.50 -- --
EPS - 5 Yr. Growth Rate -- 39.08 10.78
Capital Spending - 5 Yr. Growth Rate -39.54 40.34 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.94 1.83 2.19
Current Ratio (MRQ) 0.94 5.26 2.98
LT Debt to Equity (MRQ) -- 24.54 12.19
Total Debt to Equity (MRQ) -- 26.17 16.46
Interest Coverage (TTM) -88.90 -97.42 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 15.24 40.81 54.46
Gross Margin - 5 Yr. Avg. 89.96 51.76 52.22
EBITD Margin (TTM) -6,209.52 -- --
EBITD - 5 Yr. Avg -383.86 -564.12 10.98
Operating Margin (TTM) -6,210.97 -706.11 4.74
Operating Margin - 5 Yr. Avg. -384.15 -585.15 6.41
Pre-Tax Margin (TTM) -6,370.48 -681.03 5.58
Pre-Tax Margin - 5 Yr. Avg. -387.78 -588.45 6.83
Net Profit Margin (TTM) -6,370.48 -682.46 1.88
Net Profit Margin - 5 Yr. Avg. -387.36 -591.46 3.10
Effective Tax Rate (TTM) -- 22.64 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.26 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 45,045 22,312,275 846,855,748
Net Income/Employee (TTM) -2,869,585 2,947,385 99,619,396
Receivable Turnover (TTM) 12.23 19.92 5.78
Inventory Turnover (TTM) 8.87 2.37 3.35
Asset Turnover (TTM) 0.21 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -1,329.05 -0.70 10.95
Return on Assets - 5 Yr. Avg. -530.60 -0.06 12.32
Return on Investment (TTM) -- 2.00 14.38
Return on Investment - 5 Yr. Avg. -- 2.81 16.11
Return on Equity (TTM) -- 3.49 16.08
Return on Equity - 5 Yr. Avg. -- 4.33 17.41
  1 Year 3 Year 5 Year
Sales % -89.73 -56.13 -38.07
EPS (TTM) % 40.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nymox Pharmaceutical Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.21%
# of Holders: 77
Total Shares Held: 3,545,543
3 Mo. Net Change: -52,226
# New Positions: 15
# Closed Positions: 5
# Increased Positions: 32
# Reduced Positions: 21
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.